Transaction · 0001867096-26-000078

McCulloch Kevin

McCulloch Kevin, SR, reported an open-market or private sale at Xeris Biopharma Holdings, Inc. involving 25000.000000 shares for an estimated $250000.00. Reported holdings after the transaction were 1614208.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSR
XERSXeris Biopharma Holdings, Inc.
Filing timeSep 29
Trade dateSep 28, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded1.53%Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,639,208 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$9.98
Pre-filing
1mo ago -15.0%1w ago -11.8%1d ago -8.8%
Returns since
7d30d90d180d1y

XERS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
XERS since 2026-09-29Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001867096-26-000078
Common Stock
Transaction date
Sep 28, 2026
Filed Sep 29, 2026, 08:59 PM · 1d delay
Shares
25.0k sh
$10.00 per share
Estimated value
-$250k
Computed from shares × price
Holdings after
1.61M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025.

  2. F2

    The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an…

Original filing · 0001867096-26-000078
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

XERS